학술논문
ATR Inhibitor AZD6738 (Ceralasertib) Exerts Antitumor Activity as a Monotherapy and in Combination with Chemotherapy and the PARP Inhibitor Olaparib
Document Type
Article
Author
Source
In: Cancer Research . (Cancer Research, 15 March 2022, 82(6):1140-1152)
Subject
Language
English
ISSN
15387445
00085472
00085472